Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4
2(66.7%)
N/A
1(33.3%)
3Total
Phase 4(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07209787Phase 4Recruiting

SIS-Reinforced vs. Conventional Anastomosis for Mid-to-Low Rectal Cancer: A Multicenter RCT on Anastomotic Leak

Role: collaborator

NCT06339385Completed

Management of PADIS in Emergency Intensive Care Unit

Role: collaborator

NCT06078839Phase 4Not Yet Recruiting

Nafamostat Mesilate in the Treatment of Severe Infection-associated Coagulopathy

Role: collaborator

NCT05088213Not ApplicableUnknown

Suction Mini-PCNL Versus Standard PCNL for the Management of 2-4cm Kidney Stones

Role: collaborator

All 4 trials loaded